GC
IOVA icon

Grimes & Company’s Iovance Biotherapeutics IOVA Stock Holding History

Grimes & Company’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.9K Sell
28,179
-1,159
-4% -$3.71K ﹤0.01% 426
2025
Q4 		$80.1K Sell
29,338
-14,007
-32% -$32.4K ﹤0.01% 456
2025
Q3 		$94.1K Buy
43,345
+5,506
+15% +$13K ﹤0.01% 446
2025
Q2 		$65.1K Buy
37,839
+5,672
+18% +$14.1K ﹤0.01% 410
2025
Q1 		$107K Sell
32,167
-1,458
-4% -$7.52K ﹤0.01% 361
2024
Q4 		$249K Hold
33,625
– – 0.01% 336
2024
Q3 		$316K Buy
33,625
+250
+0.7% +$2.37K 0.01% 282
2024
Q2 		$268K Buy
33,375
+4,125
+14% +$44.2K 0.01% 285
2024
Q1 		$433K Sell
29,250
-5,748
-16% -$66.9K 0.01% 239
2023
Q4 		$285K Buy
34,998
+20,227
+137% +$106K 0.01% 263
2023
Q3 		$67.2K Sell
14,771
-462
-3% -$3.02K ﹤0.01% 292
2023
Q2 		$107K Buy
+15,233
New +$109K ﹤0.01% 297

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return